Prudential Financial Inc Acadia Pharmaceuticals Inc Transaction History
Prudential Financial Inc
- $67.5 Billion
- Q1 2025
A detailed history of Prudential Financial Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Prudential Financial Inc holds 354,601 shares of ACAD stock, worth $8.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
354,601
Previous 253,961
39.63%
Holding current value
$8.14 Million
Previous $4.66 Million
26.37%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$984 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$349 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$277 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$196 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$161 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.71B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...